Clene Financials
| CLNN Stock | USD 4.56 0.13 2.93% |
Clene |
Understanding current and past Clene Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Clene's financial statements are interrelated, with each one affecting the others. For example, an increase in Clene's assets may result in an increase in income on the income statement.
Clene Stock Summary
Clene competes with MediciNova, Molecular Partners, Champions Oncology, Century Therapeutics, and Kezar Life. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.Specialization | Consumer Defensive, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US1856341029 |
| CUSIP | 185634102 185634201 G8959N106 G8959N130 |
| Location | Utah; U.S.A |
| Business Address | 6550 South Millrock |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | clene.com |
| Phone | 801 676 9695 |
| Currency | USD - US Dollar |
Clene Key Financial Ratios
| Return On Equity | -4.17 | ||||
| Return On Asset | -0.47 | ||||
| Target Price | 45.17 | ||||
| Number Of Employees | 82 | ||||
| Beta | 0.26 |
Clene Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Clene's current stock value. Our valuation model uses many indicators to compare Clene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clene competition to find correlations between indicators driving Clene's intrinsic value. More Info.Clene Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clene's earnings, one of the primary drivers of an investment's value.Clene Inc Systematic Risk
Clene's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Clene volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on Clene Inc correlated with the market. If Beta is less than 0 Clene generally moves in the opposite direction as compared to the market. If Clene Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Clene Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Clene is generally in the same direction as the market. If Beta > 1 Clene moves generally in the same direction as, but more than the movement of the benchmark.
Clene March 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Clene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clene Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clene Inc based on widely used predictive technical indicators. In general, we focus on analyzing Clene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clene's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.16 | |||
| Information Ratio | 0.0883 | |||
| Maximum Drawdown | 17.63 | |||
| Value At Risk | (4.85) | |||
| Potential Upside | 5.93 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.